Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis

View ORCID ProfileMichael R. Abidin, View ORCID ProfileOral Alpan, View ORCID ProfileMatthew Plassmeyer, View ORCID ProfileLina Kozhaya, Denise Loizou, View ORCID ProfileMikail Dogan, View ORCID ProfileZachary Upchurch, View ORCID ProfileNathan P Manes, View ORCID ProfileAleksandra Nita-Lazar, View ORCID ProfileDerya Unutmaz, View ORCID ProfileSøren Ulrik Sønder
doi: https://doi.org/10.1101/2023.12.11.23299743
Michael R. Abidin
1Metropolitan ENT, 6355 Walker Ln, Alexandria, VA-22310, USA
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael R. Abidin
Oral Alpan
2Amerimmune LLC, 8260 Greensboro Dr VA-22102 McLean,, USA
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oral Alpan
Matthew Plassmeyer
2Amerimmune LLC, 8260 Greensboro Dr VA-22102 McLean,, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Plassmeyer
Lina Kozhaya
3The Jackson Laboratory, Farmington, CT, 06032 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lina Kozhaya
Denise Loizou
2Amerimmune LLC, 8260 Greensboro Dr VA-22102 McLean,, USA
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikail Dogan
3The Jackson Laboratory, Farmington, CT, 06032 USA
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mikail Dogan
Zachary Upchurch
1Metropolitan ENT, 6355 Walker Ln, Alexandria, VA-22310, USA
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zachary Upchurch
Nathan P Manes
4Functional Cellular Networks Section, Laboratory of Immune System Biology, NIAID, NIH, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nathan P Manes
Aleksandra Nita-Lazar
4Functional Cellular Networks Section, Laboratory of Immune System Biology, NIAID, NIH, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aleksandra Nita-Lazar
Derya Unutmaz
3The Jackson Laboratory, Farmington, CT, 06032 USA
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Derya Unutmaz
Søren Ulrik Sønder
2Amerimmune LLC, 8260 Greensboro Dr VA-22102 McLean,, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Søren Ulrik Sønder
  • For correspondence: ssonder{at}amerimmune.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective: Chronic rhinosinusitis (CRS) impacts an estimated 5% to 15% of people worldwide, incurring significant economic healthcare burden. There is a urgent need for the discovery of predictive biomarkers to improve treatment strategies and outcomes for CRS patients.

Study design: Cohort study of CRS patients and healthy controls using blood samples. Setting: Out-patient clinics.

Methods: Whole blood samples were collected for flow cytometric analysis. Mechanistic studies involved the transfection of human primary T cells and Jurkat cells.

Results: Our analysis began with a 63-69 year-old female patient diagnosed with refractory CRS,. Despite undergoing multiple surgeries, she continually faced sinus infections. Whole exome sequencing pinpointed a heterozygous IL-12Rb1 mutation situated in the linker region adjacent to the cytokine binding domain. When subjected to IL-12 stimulation, the patient’s CD4 T-cells exhibited diminished STAT4 phosphorylation. However, computer modeling or T-cell lines harboring the same IL-12 receptor mutation did not corroborate the hypothesis that IL-12Rb could be responsible for the reduced phosphorylation of STAT4 by IL-12 stimulation.

Upon expanding our investigation to a broader CRS patient group using the pSTAT4 assay, we discerned a subset of refractory CRS patients with abnormally low STAT4 phosphorylation.

The deficiency showed improvement both in-vitro and in-vivo after exposure to Latilactobacillus sakei (aka Lactobacillus sakei), an effect at least partially dependent on IL-12.

Conclusion: In refractory CRS patients, an identified STAT4 defect correlates with poor clinical outcomes after sinus surgery, which can be therapeutically targeted by Latilactobacillus sakei treatment. Prospective double-blind placebo-controlled trials are needed to validate our findings.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by Amerimmune. This study was supported in part by the Intramural Research Program of NIAID, NIH and internal funds to D.U. at Jackson Laboratory.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The studies involving human participants were reviewed and approved by Western Institutional Review Board (WIRB) Protocol #1285028. Written, informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ORCID

    Michael R. Abidin M.D. 0000-0001-5679-6667

    Oral Alpan M.D. 0000-0001-7467-8541

    Matthew Plassmeyer PhD 0000-0001-8068-2125

    Lina Kozhaya 0000-0002-1559-2278

    Denise Loizou RN

    Zachary Upchurch M.D 0009-0001-1357-5765

    Nathan P Manes PhD 0000-0001-6701-3314

    Aleksandra Nita-Lazar PhD 0000-0002-8523-605X

    Mikail Dogan M.D 0000-0001-8725-9151

    Derya Unutmaz, M.D. 0000-0001-8898-6633

    Søren Ulrik Sønder PhD 0000-0002-4697-8421

  • Previous publication: This paper is uploaded to Medrxiv

  • Conflict of interest: The Author(s) declare(s) that there is no conflict of interest.

  • Contributions:

    Michael R. Abidin: Design, Conduct, Analysis

    Oral Alpan: Design, Conduct, Analysis

    Matthew Plassmeyer: Conduct, Analysis

    Lina Kozhaya: Conduct, Analysis

    Denise Loizou: Conduct

    Zachary Upchurch: Conduct

    Nathan P Manes: Conduct, Analysis

    Aleksandra Nita-Lazar: Design

    Mikail Dogan: Conduct, Analysis

    Derya Unutmaz: Design, Analysis

    Søren Ulrik Sønder: Design, Conduct, Analysis

  • Funding source: This study was supported by Amerimmune. This study was supported in part by the Intramural Research Program of NIAID, NIH and internal funds to D.U. at Jackson Laboratory.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted December 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
Michael R. Abidin, Oral Alpan, Matthew Plassmeyer, Lina Kozhaya, Denise Loizou, Mikail Dogan, Zachary Upchurch, Nathan P Manes, Aleksandra Nita-Lazar, Derya Unutmaz, Søren Ulrik Sønder
medRxiv 2023.12.11.23299743; doi: https://doi.org/10.1101/2023.12.11.23299743
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
Michael R. Abidin, Oral Alpan, Matthew Plassmeyer, Lina Kozhaya, Denise Loizou, Mikail Dogan, Zachary Upchurch, Nathan P Manes, Aleksandra Nita-Lazar, Derya Unutmaz, Søren Ulrik Sønder
medRxiv 2023.12.11.23299743; doi: https://doi.org/10.1101/2023.12.11.23299743

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Otolaryngology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5131)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)